-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
- Cosmetic Ingredient
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
Medicine Network November 19th, recently, Sichuan Colum Pharmaceuticals fat lactate amino acid (17) glucose (11%) injection, Jiangsu Hausen Pharmaceuticals injection of tygatin have been evaluated, are the first in the country.
2019, China's public medical institutions terminal fat lactate glucose injections, injections of cyclocycline sales of more than 2 billion yuan.
Fat Lactate (17) Glucose (11%) injection is an "all-in-one" intestinal nutrition three-cavity bag product, mainly used for insanity or can not be ingested through the mouth /intestinal nutrition of adult patients nutritional supplements. according to
meters of intranet data, in 2019 China's urban public hospitals, county-level public hospitals, urban community centers and township hospitals (China's public medical institutions) terminal fat lactate glucose injection sales of more than 2 billion yuan, currently only Colum Pharmaceuticals fat lactose (17) glucose (11%) injections through consistent evaluation.
: Colum Pharmaceutical Injection Review Source: MED2.0 China Drug Review Database Currently, Six injections of Colum Pharmaceuticals have passed or are evaluated as consistent, with fatty lactominate amino acids (17) Glucose (11%) injections, compound amino acids (16AA-II.)/glucose (48%) electrolyte injections, pyrethroid injections were evaluated exclusively.
Tidecycline is a new broad-spectrum antibiotic developed by Pfizer, which is also active against methicillin-resistant Staphylococcus aureus, and is the first FDA-approved glycine cyclocycline antibiotic for clinical intravenous administration.
currently has the number of enterprises in China with injection of cyclocytin production approval up to 9.
2019, sales of end-injection estration in China's public medical institutions exceeded 2.5 billion yuan, up 25.35 percent year-on-year, according to the company's internal network data.
Pharmaceuticals, the original research manufacturer Pfizer market share of more than 30%, of which Howson Pharmaceuticals slightly better. Form
: Injection with tygacycline consistency evaluation in review (including the new classification of production) Source: Minenet MED2.0 China Drug Review Database 6 enterprises submitted supplementary applications for injection tygacycline consistency evaluation, of which Jiangsu Haussen Pharmaceutical Products have been successfully evaluated, the first in China;
source: Mi Net database, state drug regulatory agency official website